212 related articles for article (PubMed ID: 25199747)
1. Risk factors associated with severity of eosinophilic otitis media.
Kanazawa H; Yoshida N; Yamamoto H; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Iino Y
Auris Nasus Larynx; 2014 Dec; 41(6):513-7. PubMed ID: 25199747
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media.
Iino Y; Usubuchi H; Kodama K; Kanazawa H; Takizawa K; Kanazawa T; Ohta Y
Otol Neurotol; 2010 Jan; 31(1):100-4. PubMed ID: 19816234
[TBL] [Abstract][Full Text] [Related]
3. Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media.
Kanazawa H; Yoshida N; Shinnabe A; Iino Y
Ann Allergy Asthma Immunol; 2014 Jul; 113(1):88-92. PubMed ID: 24863399
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media.
Iino Y; Takahashi E; Ida S; Kikuchi S
Auris Nasus Larynx; 2019 Apr; 46(2):196-203. PubMed ID: 30122651
[TBL] [Abstract][Full Text] [Related]
6. New Insights into Eosinophilic Otitis Media.
Kanazawa H; Yoshida N; Iino Y
Curr Allergy Asthma Rep; 2015 Dec; 15(12):76. PubMed ID: 26546407
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease.
Iino Y; Tomioka-Matsutani S; Matsubara A; Nakagawa T; Nonaka M
Auris Nasus Larynx; 2011 Aug; 38(4):456-61. PubMed ID: 21251776
[TBL] [Abstract][Full Text] [Related]
8. Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry.
Iino Y; Kakizaki K; Saruya S; Katano H; Komiya T; Kodera K; Ohta K
Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1109-14. PubMed ID: 17043260
[TBL] [Abstract][Full Text] [Related]
9. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media.
Iino Y; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Kanazawa H; Yoshida N
Acta Otolaryngol; 2014 Apr; 134(4):366-72. PubMed ID: 24628335
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma.
Iino Y; Nagamine H; Kakizaki K; Komiya T; Katano H; Saruya S; Kodera K
Ann Allergy Asthma Immunol; 2006 Dec; 97(6):761-6. PubMed ID: 17201235
[TBL] [Abstract][Full Text] [Related]
11. Eosinophilic otitis media; state-of-the-art diagnosis and treatment.
Iino Y
Auris Nasus Larynx; 2023 Aug; 50(4):479-489. PubMed ID: 36528403
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab.
Suzaki I; Kimura Y; Tanaka A; Hirano K; Ishibashi A; Mizuyoshi T; Ando I; Kitajima T; Watanabe S; Hinohira Y; Kobayashi H
Auris Nasus Larynx; 2019 Feb; 46(1):141-146. PubMed ID: 29909018
[TBL] [Abstract][Full Text] [Related]
13. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma.
Iino Y; Usubuchi H; Kodama K; Takizawa K; Kanazawa T; Ohta Y
Otol Neurotol; 2008 Oct; 29(7):949-52. PubMed ID: 18758390
[TBL] [Abstract][Full Text] [Related]
14. Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma.
Iino Y; Sekine Y; Yoshida S; Kikuchi S
Auris Nasus Larynx; 2021 Jun; 48(3):353-360. PubMed ID: 32943257
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic otitis media is associated with asthma severity and smoking history.
Seo Y; Nonaka M; Tagaya E; Tamaoki J; Yoshihara T
ORL J Otorhinolaryngol Relat Spec; 2015; 77(1):1-9. PubMed ID: 25633710
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for bacterial infection to cause sensorineural hearing loss in eosinophilic otitis media.
Masuda M; Esu Y; Iino Y; Yoshida N
Auris Nasus Larynx; 2021 Apr; 48(2):207-213. PubMed ID: 32883575
[TBL] [Abstract][Full Text] [Related]
17. Higher Prevalence and Severity of Eosinophilic Otitis Media in Patients with Asthma-COPD Overlap Compared with Asthma Alone.
Sato E; Seo Y; Tagaya E; Yagi O; Yamamura Y; Nonaka M
Int Arch Allergy Immunol; 2023; 184(11):1116-1125. PubMed ID: 37619543
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilic otitis media diagnosis using flow cytometric immunophenotyping.
Saliba I; Alzahrani M; Weng X; Bestavros A
Acta Otolaryngol; 2018 Feb; 138(2):110-115. PubMed ID: 29037099
[TBL] [Abstract][Full Text] [Related]
19. Anatomical Features Around Eustachian Tube in Eosinophilic Otitis Media With Eosinophilic Sinusitis.
Ohira S; Komori M; Matsui H; Furuya H; Kajiwara R; Matsuura K; Wada K
Laryngoscope; 2021 Oct; 131(10):E2689-E2695. PubMed ID: 34060671
[TBL] [Abstract][Full Text] [Related]
20. Eosinophilic otitis media: a new middle ear disease entity.
Iino Y
Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
